inc

Zscaler ThreatLabz Reveals 67% Jump in Android Malware and 40% of IoT Attacks Target Critical Industries and Hybrid Work

Key Findings: Critical infrastructure in the energy sector experienced a 387% increase in attacks compared to the previous yearIndia continues…

3 weeks ago

Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa

DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive long-term safety results from its EXTEND study, a…

3 weeks ago

LANZAJET ANNOUNCES SELECTION OF FLUOR CORPORATION FOR FRONT-END ENGINEERING AND DESIGN (FEED) FOR PROJECT SPEEDBIRD – LANZAJET’S FLAGSHIP UK SAF PLANT

CHICAGO, Nov. 4, 2025 /PRNewswire/ -- LanzaJet, Inc., a leading next-gen fuels technology company and producer of sustainable fuels, has…

3 weeks ago

Oscar Launches New Affordable Health Insurance Choices for San Antonio Individuals, Families, and Businesses

SAN ANTONIO--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today is introducing affordable, tech-powered health plans…

3 weeks ago

Fangzhous XingJie LLM Completes Key National Filing, Setting Stage for Further AI-Driven Chronic Care Innovations

SHENZHEN, China, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leader in AI-driven…

3 weeks ago

Edesa Biotech Announces Upcoming Conference Schedule

TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics…

3 weeks ago

FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

October 31, 2025 16:30 ET  | Source: FibroBiologics, Inc. Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628,…

3 weeks ago

MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication

Study published in the Journal of Atherosclerosis and Thrombosis demonstrates tipelukast (MN-001 and its metabolite MN-002) has influence on cholesterol…

4 weeks ago

Bright Minds Biosciences toPresent at Upcoming Conferences

October 30, 2025 18:30 ET  | Source: Bright Minds Biosciences NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bright Minds…

4 weeks ago